Eric I. Richman - 01 Jul 2024 Form 4 Insider Report for Gain Therapeutics, Inc. (GANX)

Role
Director
Signature
/s/ Eric Richman
Issuer symbol
GANX
Transactions as of
01 Jul 2024
Net transactions value
+$20,670
Form type
4
Filing time
01 Jul 2024, 17:00:27 UTC
Previous filing
26 Jun 2024
Next filing
25 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GANX Common Stock Purchase $6,150 +5,000 +1.8% $1.23* 277,629 01 Jul 2024 Direct
transaction GANX Common Stock Purchase $14,520 +12,000 +4.3% $1.21* 289,629 01 Jul 2024 Direct
holding GANX Common Stock 14,829 01 Jul 2024 By Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares are held by the Eric I. Richman Living Trust (the "Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of the shares held by the Trust except to the extent of his proportionate pecuniary interest therein.